Page last updated: 2024-11-05

troglitazone and Heart Disease, Ischemic

troglitazone has been researched along with Heart Disease, Ischemic in 3 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
" We previously demonstrated that chronic pretreatment with a thiazolidinedione peroxisome proliferator-activated receptor (PPAR)-gamma activator, troglitazone, improves recovery of left ventricular (LV) function and substrate metabolism after ischemia and reperfusion, without causing arrhythmias."3.72Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs. ( Gen, M; Greyson, C; Kinugawa, K; Lee, J; Long, CS; Lu, L; Schwartz, GG; Xu, Y, 2003)
"Troglitazone treatment did not attenuate the insulinopenia and hyperglycemia of diabetic rats, but it partially improved the hypertriglyceridemia."1.29Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats. ( Higa, S; Komiya, I; Nagamine, F; Shimabukuro, M; Shinzato, T; Takasu, N, 1996)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, Y2
Lu, L2
Greyson, C1
Lee, J1
Gen, M1
Kinugawa, K1
Long, CS1
Schwartz, GG2
Shimabukuro, M1
Higa, S1
Shinzato, T1
Nagamine, F1
Komiya, I1
Takasu, N1
Zhu, P1

Other Studies

3 other studies available for troglitazone and Heart Disease, Ischemic

ArticleYear
Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.
    Diabetes, 2003, Volume: 52, Issue:5

    Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Chromans; Disease Models, Animal; Gene Expression Reg

2003
Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:9

    Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Chromans; Diabetes Mellitus, Experimental; Heart;

1996
Troglitazone improves recovery of left ventricular function after regional ischemia in pigs.
    Circulation, 2000, Mar-14, Volume: 101, Issue:10

    Topics: Animals; Blood Pressure; Chromans; Hypoglycemic Agents; Insulin Resistance; Myocardial Ischemia; Oxy

2000